Stay updated on AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial page.

Latest updates to the AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry (v3.5.4) is now present in the record history, signaling a routine update to the page; no study details or content are altered by this revision.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s footer software/UI version indicator was updated from v3.5.2 to v3.5.3, reflecting a site release rather than any change to the study record itself.SummaryDifference0.1%

- Check29 days agoChange DetectedNew revision entry v3.5.2 added to the study record history, and the previous v3.5.0 entry removed.SummaryDifference0.1%

- Check58 days agoChange Detected- Revision history updated: Added v3.5.0 and removed v3.4.3.SummaryDifference0.1%

- Check65 days agoChange DetectedThe Record History now shows a new Revision: v3.4.3 and removes the previous Revision: v3.4.2 from the list.SummaryDifference0.1%

- Check94 days agoChange DetectedRevision v3.4.2 was added to the Record History, and the previous funding notice and Revision v3.4.1 entry were removed from the history.SummaryDifference0.8%

Stay in the know with updates to AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial page.